"The deal includes an upfront payment of $2m payable in cash or NantCell common stock."
Bailian Group has acquired approximately 23.4% stake comprising 52,185,126 A shares of Shanghai No1 Pharmacy.
The acquirer is an operator of departmental stores and shopping malls in China, while the target company operates a pharmacy chain in the same country.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.
Excellence in Action Recognised with 2025 Excellence Awards for Research and Development and Marketing, Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.
